Anemone altaica Induces Apoptosis in Human Osteosarcoma Cells
Abstract
In the past decade, no significant improvement has been made in chemotherapy for osteosarcoma (OS). To develop improved agents against OS, we screened 70 species of medicinal plants and treated two human OS cell lines with different agent concentrations. We then examined cell viability using the MTT assay. Results showed that a candidate plant, particularly the rhizomes of Anemone altaica Fisch. ex C. A. Mey aqueous extract (AAE), suppressed the viability of HOS and U2OS cells in a concentration-dependent manner. Flow cytometry analysis revealed that AAE significantly increased the amount of cell shrinkage (Sub-G1 fragments) in HOS and U2OS cells. Moreover, AAE increased cytosolic cytochrome c and Bax, but decreased Bcl-2. The amount of cleaved caspase-3 and poly-(ADP-ribose) polymerase-1 (PARP-1) were significantly increased. AAE suppressed the growth of HOS and U2OS through the intrinsic apoptotic pathway. Data suggest that AAE is cytotoxic to HOS and U2OS cells and has no significant influence on human osteoblast hFOB cells. The high mRNA levels of apoptosis-related factors (PPP1R15A, SQSTM1, HSPA1B, and DDIT4) and cellular proliferation markers (SKA2 and BUB1B) were significantly altered by the AAE treatment of HOS and U2OS cells. Results show that the anticancer activity of AAE could up-regulate the expression of a cluster of genes, especially those in the apoptosis-related factor family and caspase family. Thus, AAE has great potential as a useful therapeutic drug for human OS.
References
- Oncogene 26 , 1324 ( 2007 ) . Crossref, Medline, ISI, Google Scholar
- J. Clin. Oncol. 20 , 776 ( 2002 ) . Crossref, Medline, ISI, Google Scholar
- J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 844 , 67 ( 2006 ) . Crossref, Medline, ISI, Google Scholar
- Expert. Rev. Anticancer Ther. 6 , 1075 ( 2006 ) . Crossref, Medline, ISI, Google Scholar
- Zhongguo Zhong Yao Za Zhi. 23 , 739 ( 1998 ) . Medline, Google Scholar
- Free Radic. Biol. Med. 51 , 813 ( 2011 ) . Crossref, Medline, ISI, Google Scholar
- Trends Pharmacol. Sci. 25 , 259 ( 2004 ) . Crossref, Medline, ISI, Google Scholar
- J. Ethnopharmacol. 146 , 243 ( 2013 ) . Crossref, Medline, ISI, Google Scholar
- Am. J. Chin. Med. 42 , 743 ( 2014 ) . Link, ISI, Google Scholar
- Cancer 89 , 1961 ( 2000 ) . Crossref, Medline, ISI, Google Scholar
- Carbohydr. Polym. 89 , 571 ( 2012 ) . Crossref, Medline, ISI, Google Scholar
- Oncologist 9 , 422 ( 2004 ) . Crossref, Medline, ISI, Google Scholar
- J. Clin. Oncol. 24 , 1161 ( 2006 ) . Crossref, Medline, ISI, Google Scholar
- Kaohsiung J. Med. Sci. 20 , 230 ( 2004 ) . Crossref, Medline, Google Scholar
- Lancet 346 , 26 ( 1995 ) . Crossref, Medline, ISI, Google Scholar
- J. Clin. Oncol. 25 , 2057 ( 2007 ) . Crossref, Medline, ISI, Google Scholar
- Anticancer Drugs 2 , 519 ( 1991 ) . Crossref, Medline, ISI, Google Scholar
- Clin. Orthop. Relat. Res. 466 , 2114 ( 2008 ) . Crossref, Medline, ISI, Google Scholar
- Br. J. Cancer. 82 , 1339 ( 2000 ) . Crossref, Medline, ISI, Google Scholar
- Science 5381 , 1312 ( 1998 ) . Crossref, ISI, Google Scholar
- Jpn. J. Clin. Oncol. 39 , 514 ( 2009 ) . Crossref, Medline, ISI, Google Scholar
- J. Cell Biochem. 103 , 9 ( 2008 ) . Crossref, Medline, ISI, Google Scholar
- J. Integr. Plant Biol. 47 , 1145 ( 2005 ) . Crossref, ISI, Google Scholar
- Zhong Yao Cai. 31 , 49 ( 2008 ) . Medline, Google Scholar
| Remember to check out the Most Cited Articles! |
|---|
|
Check out our Chinese Medicine Titles today. |


